3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Interventions
Magnetic Resonance Spectroscopy
107
Specimen Handling
86
pembrolizumab
77
enzalutamide
59
Nivolumab
57
Gemcitabine
55
Docetaxel
50
Androgen Antagonists
44
apalutamide
41
Radiosurgery
41
Prednisone
40
Abiraterone Acetate
39
darolutamide
37
Cisplatin
36
Biopsy
35
Radiotherapy
33
cabozantinib
31
Carboplatin
29
abiraterone
28
Ipilimumab
28
Pluvicto
26
Leuprolide
25
durvalumab
24
X-Rays
23
Radiation
23
enfortumab vedotin
22
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
19
Standard of Care
19
olaparib
18
avelumab
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
FAPI-46
×
Genitourinary
×
90 days
×
Clear all
No trials found.